Apixaban vs rivaroxaban in patients with atrial fibrillation at high or low bleeding risk: A population-based cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Apixaban vs rivaroxaban in patients with atrial fibrillation at high or low bleeding risk: A population-based cohort study

Published:2024-08 Issue: Volume: Page:
ISSN:1547-5271
Container-title:Heart Rhythm
language:en
Short-container-title:Heart Rhythm

Author:

Shurrab Mohammed^ORCID,Austin Peter C.,Jackevicius Cynthia A.,Tu Karen,Qiu Feng,Haldenby Olivia,Davies Steven,Lopes Renato D.,Baykaner Tina,Johnson Linda S.,Healey Jeff S.,Ko Dennis T.

Funder

Vetenskapsrådet

Laurentian University

University of Toronto

Department of Family and Community Medicine, University of Toronto

Hjärt-Lungfonden

Publisher

Elsevier BV

Reference33 articles.

1. The CHA2DS2-vasc score predicts major bleeding in non-valvular atrial fibrillation patients who take oral anticoagulants;Lee;J Clin Med,2018

2. Bleeding with anticoagulation therapy—who is at risk, and how best to identify such patients;Palareti;Thromb Haemost,2009

3. Association between concurrent use of amiodarone and DOACs and risk of bleeding in patients with atrial fibrillation;Shurrab;Am J Cardiol,2023

4. Trends and variation in oral anticoagulant choice in patients with atrial fibrillation, 2010–2017;Zhu;Pharmacotherapy,2018

5. Clinician trends in prescribing direct oral anticoagulants for US medicare beneficiaries;Wheelock;JAMA Netw Open,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP